GeoVax Labs Inc. (GOVX)
NASDAQ: GOVX
· Real-Time Price · USD
0.91
-0.01 (-0.55%)
At close: May 15, 2025, 3:59 PM
0.93
2.19%
After-hours: May 15, 2025, 06:39 PM EDT
GeoVax Labs Revenue Breakdown
| Period Ending | Dec 31, 2022 |
|---|---|
| NIH Grants Revenue | 81.53K |
| NIH Grants Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.69M | 1.6M | 1.24M | 1.09M | 1.44M | 1.44M | 1.65M | 1.46M | 1.45M | 1.62M | 1.25M | 935.31K | 1.18M | 1.01M | 757.43K | 733.5K | 1.07M | 831.36K | 435.01K | 427.29K | 502.35K | 423.49K | 291.48K | 412.65K | 510.06K | 471.87K | 458.97K | 359.2K | 357.23K | 247.37K | 340.14K | 352K | 292K | 659.4K | 220.71K | 344.82K | 907K | 311.5K | 336K | 364.89K | 401.44K |
| Selling, General, and Administrative Revenue Growth | +5.42% | +28.97% | +14.29% | -24.46% | +0.01% | -12.96% | +13.21% | +0.56% | -10.59% | +29.90% | +33.57% | -20.67% | +16.22% | +33.94% | +3.26% | -31.56% | +28.91% | +91.11% | +1.81% | -14.94% | +18.62% | +45.29% | -29.37% | -19.10% | +8.09% | +2.81% | +27.78% | +0.55% | +44.41% | -27.28% | -3.37% | +20.55% | -55.72% | +198.77% | -35.99% | -61.98% | +191.17% | -7.29% | -7.92% | -9.11% | n/a |
| Research and Development Revenue | 5.35M | 7.61M | 7.4M | 4.28M | 4.43M | 6.23M | 6.95M | 4.72M | 2.82M | 3.76M | 2.72M | 1.31M | 1.33M | 12.89M | 1.22M | 832.84K | 602.78K | 757.35K | 416.76K | 461.42K | 808.94K | 436.1K | 467.67K | 451.23K | 555.72K | 461.76K | 557.7K | 372.2K | 486.99K | 449.26K | 498.2K | 518K | 552K | 451.34K | 683.94K | 397.58K | 438K | 542.27K | 378K | 384.65K | 403.63K |
| Research and Development Revenue Growth | -29.62% | +2.77% | +73.09% | -3.36% | -29.01% | -10.28% | +47.21% | +67.43% | -25.12% | +38.34% | +108.17% | -1.76% | -89.68% | +953.14% | +47.01% | +38.16% | -20.41% | +81.72% | -9.68% | -42.96% | +85.49% | -6.75% | +3.64% | -18.80% | +20.35% | -17.20% | +49.84% | -23.57% | +8.40% | -9.82% | -3.82% | -6.16% | +22.30% | -34.01% | +72.03% | -9.23% | -19.23% | +43.46% | -1.73% | -4.70% | n/a |